Literature DB >> 9014918

Effect of diagnosis of "smoker's lung". RYLUNG Group.

C J Brandt, H Ellegaard, M Joensen, F V Kallan, A D Sorknaes, L Tougaard.   

Abstract

Mesh:

Year:  1997        PMID: 9014918     DOI: 10.1016/s0140-6736(05)64863-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Information for patients.

Authors:  J C Wyatt
Journal:  J R Soc Med       Date:  2000-09       Impact factor: 5.344

Review 2.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Randomised controlled trial of structured personal care of type 2 diabetes mellitus.

Authors:  N F Olivarius; H Beck-Nielsen; A H Andreasen; M Hørder; P A Pedersen
Journal:  BMJ       Date:  2001-10-27

Review 4.  Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

Authors:  M Thabane
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

5.  Long-Term Effect of Interactive Online Dietician Weight Loss Advice in General Practice (LIVA) Protocol for a Randomized Controlled Trial.

Authors:  Carl J Brandt; Vibeke Brandt; Mathilde Pedersen; Dorte Glintborg; Søren Toubro; Jesper Bo Nielsen; Gunther Eysenbach; Kirsten Brandt; Jens Søndergaard
Journal:  Int J Family Med       Date:  2014-03-30

6.  Effective behaviour change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Yvonne K Bartlett; Paschal Sheeran; Mark S Hawley
Journal:  Br J Health Psychol       Date:  2013-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.